Format

Send to

Choose Destination
See comment in PubMed Commons below
Chest. 2014 May;145(5):972-980. doi: 10.1378/chest.13-1328.

Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index.

Author information

1
Internal Medicine Service, Hospital Universitario Mutua De Terrassa, Universidad de Barcelona, Barcelona. Electronic address: 19908pam@comb.cat.
2
Programa de Epidemiología e Investigación Clínica, Fundación Caubet-Cimera, Centro Internacional de Medicina Respiratoria Avanzada, Baleares.
3
Internal Medicine Service, Hospital General Universitario Gregorio Marañón, Madrid.
4
Internal Medicine Service, Hospital de Mataró, Barcelona.
5
Internal Medicine Service, Hospital Juan Negrín, Gran Canaria.
6
Respiratory Service, Hospital Universitario Mutua De Terrassa, Universidad de Barcelona, Barcelona.
7
Internal Medicine Service, Hospital Royo Villanova, Zaragoza, Spain.
8
Medical Department, Laboratorios Chiesi, Barcelona.

Abstract

BACKGROUND:

No valid tools exist for evaluating the prognosis in the short and medium term after hospital discharge of patients with COPD. Our hypothesis was that a new index based on the CODEX (comorbidity, obstruction, dyspnea, and previous severe exacerbations) index can accurately predict mortality, hospital readmission, and their combination for the period from 3 months to 1 year after discharge in patients hospitalized for COPD.

METHODS:

A multicenter study of patients hospitalized for COPD exacerbations was used to develop the CODEX index, and a different patient cohort was used for validation. Comorbidity was measured using the age-adjusted Charlson index, whereas dyspnea, obstruction, and severe exacerbations were calculated according to BODEX (BMI, airfl ow obstruction, dyspnea, and previous severe exacerbations) thresholds. Information about mortality and readmissions for COPD or other causes was collected at 3 and 12 months after hospital discharge.

RESULTS:

Two sets of 606 and 377 patients were included in the development and validation cohorts, respectively. The CODEX index was associated with mortality at 3 months ( P < .0001; hazard ratio [HR], 1.5; 95% CI, 1.2-1.8) and 1 year ( P < .0001; HR, 1.3; 95% CI, 1.2-1.5 ), hospital readmissions in the same periods, and their combination (all P < .0001). All CODEX C statistics were superior to those of the BODEX, DOSE (dyspnea, airfl ow obstruction, smoking status, and exacerbation frequency), and updated ADO (age, dyspnea, and airfl ow obstruction) indexes.

CONCLUSIONS:

The CODEX index was a useful predictor of survival and readmission at both 3 months and 1 year after hospital discharge for a COPD exacerbation, with a prognostic capacity superior to other previously published indexes.

PMID:
24077342
DOI:
10.1378/chest.13-1328
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center